MR编号 | SE/H/0861/001 |
---|
药品名称 | SmofKabiven Perifer |
---|
活性成分 | - Tryptophan 0.63 g
- Tyrosine 0.12 g
- Valine 2.0 g
- Alanine 4.4 g
- Arginine 3.8 g
- Calcium chloride 0.18 g
- fish oil, rich in omega 3-acids 4.2 g
- Glucose monohydrate 71.0 g
- Glycine 3.5 g
- Isoleucine 1.6 g
- Lysine 2.1 g
- Magnesium sulfate 0.38 g
- medium-chain triglycerides 8.5 g
- Methionine 1.3 g
- OLIVE OIL monohydrate 7.0 g
- Phenylalanine 1.6 g
- Potassium chloride 1.4 g
- Sodium glycerophosphate 1.3 g
- Sodium acetate 1.1 g
- SOYBEAN OIL monohydrate 8.5 g
- Taurine 0.32 g
- Threonine 1.4 g
- Leucine 2.3 g
- Histidine 0.93 g
- Zinc sulfate 0.0 g
- Serine 2.1 g
- Proline 3.5 g
|
---|
剂型 | Emulsion for infusion |
---|
上市许可持有人 | Fresenius Kabi AB
751 74 Uppsala
Sweden |
---|
参考成员国 - 产品名称 | Sweden (SE) |
---|
互认成员国 - 产品名称 | - Germany (DE)
- Denmark (DK)
- Belgium (BE)
- Netherlands (NL)
- Luxembourg (LU)
- Iceland (IS)
- United Kingdom (Northern Ireland) (XI)
- Ireland (IE)
- Austria (AT)
SmofKabiven peripher Emulsion zur Infusion - Spain (ES)
- Portugal (PT)
- Greece (GR)
- Norway (NO)
- Finland (FI)
- Poland (PL)
Smofkabiven Peripheral - Latvia (LV)
- Lithuania (LT)
SmofKabiven Peripheral infuzinė emulsija - Estonia (EE)
- Hungary (HU)
SMOFKABIVEN PERIPHERAL emulziós infúzió - Bulgaria (BG)
- Cyprus (CY)
- Czechia (CZ)
- Romania (RO)
Smofkabiven Peripheral, emulsie perfuzabila - Slovakia (SK)
- Slovenia (SI)
|
---|
许可日期 | 2008/12/09 |
---|
最近更新日期 | 2025/02/07 |
---|
药物ATC编码 | |
---|
申请类型 | - TypeLevel1:Known Active Substance
- TypeLevel2:Initial Application
- TypeLevel3:Full Dossier Art 8.3(i) Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|